Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: Confirmation of a relationship by immunohistochemical analysis

Dermatology

Volumn 219, Issue 2, 2009, Pages 174-178

  Stoebner, P E ^a,b   Fabre, C ^a   Delfour, C ^a   Joujoux, J M ^a   Roger, P ^a   Dandurand, M ^a   Meunier, L ^a,b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b CNRS   (France)

Author keywords

Hereditary nonpolyposis colorectal cancer; MSH2 immunostaining; Muir Torre syndrome; Solitary subungual keratoacanthoma

Indexed keywords

PROTEIN MSH2;

ABDOMEN; ADULT; ARTICLE; CANCER SCREENING; CASE REPORT; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; EPIDERMIS; EPITHELIUM TUMOR; EXCISION; FAMILY HISTORY; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; KERATOACANTHOMA; MALE; MISMATCH REPAIR; MUIR TORRE SYNDROME; OLIVARY NUCLEUS; PARAKERATOSIS; PELVIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SKIN DEFECT; SKIN TUMOR; SOLITARY SUBUNGUAL SERATOACANTHOMA; THORAX RADIOGRAPHY; THUMB; TUMOR CELL;

ADULT; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALE; MUTS HOMOLOG 2 PROTEIN; NAIL DISEASES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THUMB; TREATMENT OUTCOME;

EID: 69349105545     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228830     Document Type: Article

References (16)

1. Lynch HT, Lynch JF, Lynch PM, Attard T: Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008; 7: 27-39.
2. Ponti G, Ponz de Leon M: Muir-Torre syndrome. Lancet Oncol 2005; 6: 980-987.
3. Lynch HT, Fusaro RM, Lynch PM: Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer. J Invest Dermatol 2006; 126: 2158-2159. (Pubitemid 44413160)
4. Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di Gregorio C, Pellacani G, et al: Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol 2006; 126: 2302-2307. (Pubitemid 44413178)
5. Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, et al, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association: Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005; 293: 1986-1994.
6. Akhtar S, Oza KK, Khan SA, Wright J: Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 1999; 41: 681-686. (Pubitemid 29514021)
7. Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A, et al: Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005; 103: 1018-1025. (Pubitemid 40270079)
8. Mathiak M, Rütten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, et al: Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002; 26: 338-343. (Pubitemid 34184457)
9. Sinha A, Marsh R, Langtry J: Spontaneous regression of subungual keratoacanthoma with reossification of underlying distal lytic phalynx. Clin Exp Dermatol 2005; 30: 20-22. (Pubitemid 40188310)
10. Scarani P, Ghigi G, Bertarelli C, Eusebi V: Subungual keratoacanthoma: a variant of verrucous squamous cell carcinoma of the skin. Appl Pathol 1983; 1: 339-342. (Pubitemid 14046007)
11. Baran R, Goettmann S: Distal digital kerato-acanthoma: a report of 12 cases and a review of the literature. Br J Dermatol 1998; 139: 512-515. (Pubitemid 28430474)
12. Keeney GL, Banks PM, Linscheid RL: Subungual keratoacanthoma: report of a case and review of the literature. Arch Dermatol 1988; 124: 1074-1076. (Pubitemid 18177973)
13. Machin P, Catasus L, Pons C, Muñoz J, Conde-Zurita JM, Balmaña J, et al: Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002; 29: 415-420. (Pubitemid 34886278)
14. Tischkowitz M, Gologan A, Srolovitz H, Khanna M, Foulkes WD: Muir-Torre syndrome and MSH2 mutations: the importance of dermatological awareness. Br J Cancer 2006; 95: 243-244. (Pubitemid 44050925)
15. Thiffault I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, et al: Germline truncating mutations in both MSH2 and BRCA2 in a single kindred. Br J Cancer 2004; 90: 483-491. (Pubitemid 38250649)
16. South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A: The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 2008; 100: 277-281.